Four recent studies in JAIDS chiefly focused on PrEP provision to cisgender women and gay and bisexual men.
The most popular form of long-acting HIV treatment; telehealth for PrEP uptake among young MSM of color; PrEP awareness and usage among Rhode Island women; assessing cognitive benefits of switching off of efavirenz.
PrEP access appears far from equal in the U.S.; HIV treatment and viral suppression disparities in Europe; how today’s hepatitis C treatments affect mortality; sex-based differences in cognitive impairment.
The benefits of pre-pregnancy HIV treatment initiation for mothers-to-be; HIV diagnoses rise among young U.S. MSM; cost effectiveness of PrEP for heterosexual women; methotrexate and arterial function.
When it comes to getting PrEP to more than just white, cisgender gay men, real talk is essential, according to Darrianne Martin, HIV prevention manager with AltaMed, an L.A.-based health center that serves primarily a Latinx population.
At CROI 2018, Tonia Poteat, Ph.D., presented research to show what can work to increase PrEP uptake among black and Latinx trans women, determine possibilities for successful interventions, and ask questions for future research.
Why PrEP Is Essential to Safeguard Black and Hispanic MSM and Transgender Women: A Blog Entry by L. Jeannine Bookhardt-Murray, M.D.
We are failing our young, black and Hispanic men who have sex with men (MSM) and transgender women. Each year in the U.S., we see nearly 50,000 new HIV infections. New York City remains the epicenter of the country's epidemic. Black MSM and black wom...